TMEM181 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.722800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.843000E-01
Normal-vs-Stage2
4.575200E-01
Normal-vs-Stage3
2.225200E-01
Normal-vs-Stage4
2.603600E-02
Stage1-vs-Stage2
4.920400E-01
Stage1-vs-Stage3
1.675780E-01
Stage1-vs-Stage4
5.056600E-01
Stage2-vs-Stage3
4.846300E-02
Stage2-vs-Stage4
7.858100E-02
Stage3-vs-Stage4
3.435100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.933200E-01
Normal-vs-AfricanAmerican
1.886840E-01
Normal-vs-Asian
7.235600E-01
Caucasian-vs-AfricanAmerican
3.192000E-01
Caucasian-vs-Asian
5.252000E-01
AfricanAmerican-vs-Asian
2.000200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.100800E-01
Normal-vs-Female
5.537400E-01
Male-vs-Female
4.941200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.037200E-01
Normal-vs-Age(41-60Yrs)
2.750000E-01
Normal-vs-Age(61-80Yrs)
5.806000E-01
Normal-vs-Age(81-100Yrs)
5.430200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.471200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.023000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.075000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.014100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.304200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.008200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.998600E-01
Normal-vs-Daily Drinker
8.753200E-01
Normal-vs-Weekly Drinker
8.592200E-01
Normal-vs-Occasional Drinker
2.214800E-01
Normal-vs-Social Drinker
6.758800E-01
Non Drinker-vs-Daily Drinker
4.380400E-01
Non Drinker-vs-Weekly Drinker
4.887200E-01
Non Drinker-vs-Occasional Drinker
8.311900E-02
Non Drinker-vs-Social Drinker
8.863000E-01
Daily Drinker-vs-Weekly Drinker
9.953400E-01
Daily Drinker-vs-Occasional Drinker
2.653700E-02
Daily Drinker-vs-Social Drinker
6.109800E-01
Weekly Drinker-vs-Occasional Drinker
4.389700E-02
Weekly Drinker-vs-Social Drinker
6.344000E-01
Occasional Drinker-vs-Social Drinker
1.246410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.280500E-02
Normal-vs-Grade 2
1.808180E-02
Normal-vs-Grade 3
2.470300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.242600E-01
Grade 1-vs-Grade 3
4.714800E-01
Grade 1-vs-Grade 4
8.280500E-02
Grade 2-vs-Grade 3
6.506600E-01
Grade 2-vs-Grade 4
1.808180E-02
Grade 3-vs-Grade 4
2.470300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.854200E-01
Normal-vs-NonDiabetic
4.883400E-01
Diabetic-vs-NonDiabetic
2.369800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.128800E-01
Normal-vs-NoPancreatitis
5.897400E-01
Pancreatitis-vs-NoPancreatitis
5.415000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.400400E-01
Normal-vs-N1
4.770600E-01
N0-vs-N1
5.450800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.431600E-01
Normal-vs-TP53-NonMutant
3.474200E-01
TP53-Mutant-vs-TP53-NonMutant
6.293200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
